Homocysteine: An Emerging Cardiovascular Risk Factor that Never Really Made it~!2009-10-29~!2009-12-27~!2010-04-08~!
The Open Clinical Chemistry Journal · 2012
DOI: 10.2174/1874241601003010019 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Clinical Chemistry Journal, 2012. Verfasst von Vasilios G. Athyros und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Serum total homocysteine (tHcy) has been implicated in promoting venous thromboembolic events and atherosclerosis, manifested as coronary heart disease, stroke or peripheral arterial disease.Dietary supplementation with B vitamins that lower tHcy concentrations was expected to reduce cardiovascular disease (CVD) risk.However, recent metaanalyses of prospective observational studies and randomized controlled trials failed to show a role of tHcy in the pathogenesis of vascular disease or a benefit of B vitamins in CVD events.This review analyzes recent data on the potential of tHcy to cause health problems (if any) and the role of vitamin B supplementation in preventing them.
Zitieren
APA
Athyros, V. G., Tziomalos, K., Karagiannis, A., & Mikhailidis, D. P. (2012). Homocysteine: An Emerging Cardiovascular Risk Factor that Never Really Made it~!2009-10-29~!2009-12-27~!2010-04-08~!. The Open Clinical Chemistry Journal. https://doi.org/10.2174/1874241601003010019
Vancouver
Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Homocysteine: An Emerging Cardiovascular Risk Factor that Never Really Made it~!2009-10-29~!2009-12-27~!2010-04-08~!. The Open Clinical Chemistry Journal. 2012. doi:10.2174/1874241601003010019
BibTeX
@article{Athyros2012,
author = {Athyros, Vasilios G. and Tziomalos, Konstantinos and Karagiannis, Asterios and Mikhailidis, Dimitri P.},
title = {Homocysteine: An Emerging Cardiovascular Risk Factor that Never Really Made it~!2009-10-29~!2009-12-27~!2010-04-08~!},
journal = {The Open Clinical Chemistry Journal},
year = {2012},
doi = {10.2174/1874241601003010019}
}
EUVIMED